May 31, 2026 07:30PM
May 12, 2026 08:00AM
Feb 9, 2026 08:00AM
Feb 5, 2026 06:30PM
Feb 5, 2026 06:30PM
Jan 14, 2026 08:25PM
Dec 17, 2025 08:00AM Ascentage Pharma to Present at 44th Annual J.P. Morgan Healthcare Conference
Dec 9, 2025 06:06AM
Dec 9, 2025 06:06AM
Dec 9, 2025 06:06AM
Dec 8, 2025 07:45PM
Dec 8, 2025 07:45PM
Dec 8, 2025 07:45PM
Dec 7, 2025 08:10PM ASH 2025 | Ascentage Pharma Presents Encouraging Data from Phase Ib/II Study of Bcl-2 Inhibitor Lisaftoclax in Venetoclax–Exposed Patients with Myeloid Malignances
Dec 6, 2025 10:15AM
Dec 4, 2025 07:00PM
Dec 1, 2025 08:00AM
Nov 24, 2025 07:00PM
Nov 19, 2025 08:00AM
Nov 3, 2025 08:10PM
Nov 3, 2025 08:10PM Ascentage Pharma to Present Data from Multiple Studies of Olverembatinib, Including the First Dataset from POLARIS-1 Study, at ASH 2025
Oct 29, 2025 08:00PM
Oct 7, 2025 08:00AM
Aug 25, 2025 08:00AM
Aug 20, 2025 07:57PM
Aug 17, 2025 07:30PM
Aug 1, 2025 08:00AM
Jul 23, 2025 08:00AM Ascentage Pharma to Participate in BTIG Virtual Biotechnology Conference 2025
Jul 17, 2025 04:30AM
Jul 14, 2025 10:36AM
Jul 14, 2025 10:35AM
Jul 14, 2025 05:57AM
Jul 14, 2025 05:23AM
Jul 10, 2025 09:31AM
Jul 10, 2025 09:30AM Ascentage Pharma Announces Its Novel Bcl-2 Inhibitor Lisaftoclax Approved by China NMPA, Ushering in a New Era for the Treatment of CLL/SLL
Jul 7, 2025 07:30PM
Jun 15, 2025 07:30PM
Jun 9, 2025 07:30PM
Jun 2, 2025 07:30PM
Jun 2, 2025 07:30PM
May 22, 2025 08:15PM
Apr 23, 2025 07:00PM Ascentage Pharma To Present Data from Two Clinical Studies at 2025 ASCO Annual Meeting, Including Oral Presentation on Its Key Assets Lisaftoclax and Alrizomadlin
Apr 21, 2025 07:01AM
Apr 21, 2025 07:00AM
Mar 25, 2025 07:00PM
Feb 7, 2025 08:25AM
Feb 7, 2025 08:24AM
Jan 28, 2025 04:01PM
Jan 24, 2025 11:03AM Ascentage Pharma (AAPG) IPO opens flat at $17.25

122,377 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All